Indaptus Therapeutics, Inc. (INDP) investor relations documents from the company's IR site: 2 presentations; latest deck 2025-05-14. Read in-app with summaries. First-party data.
https://indaptusrx.com/investors/wp-content/uploads/2025/05/INDP-May-2025.pdf: Indaptus Therapeutics May 2025 corporate presentation outlining the clinical development status and strategic outlook for its lead product candidate, Decoy20.
| Published | Type | Document |
|---|---|---|
| 2025-05-14 | Presentation | https://indaptusrx.com/investors/wp-content/uploads/2025/05/INDP-May-2025.pdf |
| 2022-10-10 | Presentation | https://indaptusrx.com/investors/wp-content/uploads/2022/10/Indaptus-Corporate-Presentation-10-25-22.pdf |
INDP overview · INDP earnings · INDP financials · INDP KPIs · INDP ownership · INDP peers · INDP filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.